Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Gene Therapy Based on CD44 Alternative Splicing
Asman, David C.
University of Pittsburgh, Pittsburgh, PA, United States
Search grants from David Asman
Search grants from University of Pittsburgh
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Regulation of Skeletal Muscle Mass
Minority Predoctoral Fellowship Program
Minority Predoctoral Fellowship Program
Activity-Based Anorexia and Norepinephrine
Synthesis of Polycyclic Aromatic Compounds to Cancer Research
Recently added grants:
A Nanopatterned Mea-Based Functional Phenotyping Assay for Drug-Induced Cardiotoxicity Screening
Adaptation and implementation of a Cherokee-based participatory research project to reduce CVD risk
Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Precision Therapy Based on Patient Specific Pathophysiology
Automatic Quantification and Labeling of Cerebral Microbleeds, Oxygen Saturation and Sources of Abnormal Susceptibility
The Neurobiology of Social Decision-Making: Social Inference and Context
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA066294-01A2
Application #
2109630
Study Section
Biological Sciences 2 (BIOL)
Project Start
1996-11-26
Project End
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
University of Pittsburgh
Department
Pathology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Publications
Resnick, D K; Resnick, N M; Welch, W C et al.
(1999)
Differential expressions of CD44 variants in tumors affecting the central nervous system.
Mol Diagn 4:219-32
Comments
Be the first to comment on David Asman's grant